Hemostastic embolization in oncology

Area of Science:

• Oncology
• Vascular Medicine
• Interventional Radiology

Background:

• Neoplastic disease presents significant bleeding risks, particularly in medically compromised patients.
• Bleeding complications, such as hemoptysis, can lead to severe outcomes like hemorrhagic shock or acute respiratory distress.
• Tumor rupture signifies advanced disease, carries a risk of metastatic spread, and implies a poor prognosis even after acute bleeding control.

Purpose of the Study:

• To review the mechanisms and implications of bleeding in neoplastic disease.
• To highlight the prognostic significance of tumor-related bleeding.
• To discuss current palliative treatment strategies for neoplastic bleeding.

Main Methods:

• Literature review of neoplastic disease and associated bleeding.
• Analysis of clinical outcomes and prognostic factors.
• Evaluation of interventional treatment modalities.

Main Results:

• Multiple mechanisms contribute to bleeding in cancer patients.
• Bleeding often occurs in vulnerable individuals and can be life-threatening.
• Tumor rupture indicates advanced malignancy and increases metastatic risk.
• Recurrent bleeding is a significant concern.
• Endovascular hemostatic embolization is the primary palliative approach.

Conclusions:

• Bleeding in neoplastic disease is a serious complication with poor prognosis.
• Tumor rupture is a marker of advanced disease and metastatic potential.
• Endovascular embolization is the established first-line palliative treatment.